Abstract:The air quality in China, particularly the PM 2.5 (particles less than 2.5 μm in aerodynamic diameter) level, has become an increasing public concern because of its relation to health risks. The distribution of PM 2.5 concentrations has a close relationship with multiple geographic and socioeconomic factors, but the lack of reliable data has been the main obstacle to studying this topic. Based on the newly published Annual Average PM 2.5 gridded data, together with land use data, gridded population data and Gross Domestic Product (GDP) data, this paper explored the spatial-temporal characteristics of PM 2.5 concentrations and the factors impacting those concentrations in China for the years of 2001-2010. The contributions of urban areas, high population and economic development to PM 2.5 concentrations were analyzed using the Geographically Weighted
OPEN ACCESS
Int. J. Environ. Res. Public Health 2014, 11
174Regression (GWR) model. The results indicated that the spatial pattern of PM 2.5 concentrations in China remained stable during the period 2001-2010; high concentrations of PM 2.5 are mostly found in regions with high populations and rapid urban expansion, including the Beijing-Tianjin-Hebei region in North China, East China (including the Shandong, Anhui and Jiangsu provinces) and Henan province. Increasing populations, local economic growth and urban expansion are the three main driving forces impacting PM 2.5 concentrations.
A decrease in visfatin level was demonstrated in pre-eclampsia, suggesting that visfatin and adipokine-associated metabolic abnormalities are involved in the pathogenesis of the disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.